Phase II Dose-Finding Study to Evaluate Efficacy and Safety of CDB-2914 in Patients with Uterine Myoma
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Ulipristal (Primary) ; Leuprorelin
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- Sponsors ASKA Pharmaceutical
- 20 Jun 2017 Status changed from active, no longer recruiting to completed.
- 25 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2016 New trial record